Delay in diphtheria, pertussis, tetanus vaccination is associated with a reduced risk of childhood asthma

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 3, 2008, Pages 626-631

  McDonald, Kara L ^a   Huq, Shamima I ^b,c,d   Lix, Lisa M ^a,c   Becker, Allan B ^a   Kozyrskyj, Anita L ^a,b,c,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Faculty of Pharmacy   (Canada)

^c Manitoba Centre for Health Policy   (Canada)

^d MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

Author keywords

administrative health data; childhood asthma; DPT combination vaccine; retrospective birth cohort

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ARTICLE; ASTHMA; CHILD CARE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNIZATION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; THERAPY DELAY; TREATMENT PLANNING;

ASTHMA; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; LONGITUDINAL STUDIES; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME;

EID: 40049109049     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.11.034     Document Type: Article

References (49)

1. Johnston S., and Holgate S. Asthma: critical debates (2002), Blackwell Science Ltd, London
2. Rook G.A., and Brunet L.R. Give us this day our daily germs. Biologist (London) 49 (2002) 145-149
3. Dannemann A., van Ree R., Kulig M., Bergmann R.L., Bauer P., Forster J., et al. Specific IgE and IgG4 immune responses to tetanus and diphtheria toxoid in atopic and nonatopic children during the first two years of life. Int Arch Allergy Immunol 111 (1996) 262-267
4. Nilsson L., Gruber C., Granstrom M., Bjorksten B., and Kjellman N.I. Pertussis IgE and atopic disease. Allergy 53 (1998) 1195-1201
5. Farooqi I.S., and Hopkin J.M. Early childhood infection and atopic disorder. Thorax 53 (1998) 927-932
6. McKeever T.M., Lewis S.A., Smith C., and Hubbard R. Vaccination and allergic disease: a birth cohort study. Am J Public Health 94 (2004) 985-989
7. Nilsson L., Kjellman N.I., and Bjorksten B. Allergic disease at the age of 7 years after pertussis vaccination in infancy: results from the follow-up of a randomized controlled trial of 3 vaccines. Arch Pediatr Adolesc Med 157 (2003) 1184-1189
8. Hurwitz E.L., and Morgenstern H. Effects of diphtheria-tetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J Manipulative Physiol Ther 23 (2000) 81-90
9. Kemp T., Pearce N., Fitzharris P., Crane J., Fergusson D., St George I., et al. Is infant immunization a risk factor for childhood asthma or allergy?. Epidemiology 8 (1997) 678-680
10. Gruber C., Illi S., Lau S., Nickel R., Forster J., Kamin W., et al. Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics 111 (2003) e282-e288
11. Bernsen R.M., de Jongste J.C., and van der Wouden J.C. Lower risk of atopic disorders in whole cell pertussis-vaccinated children. Eur Respir J 22 (2003) 962-964
12. Möhrenschlager M., Haberl V.M., Krämer U., Behrendt H., and Ring J. Early BCG and pertussis vaccination and atopic diseases in 5- to 7-year-old preschool children from Augsburg, Germany: results from the MIRIAM study. Pediatr Allergy Immunol 18 (2007) 5-9
13. Maitra A., Sherriff A., Griffiths M., and Henderson J. Pertussis vaccination in infancy and asthma or allergy in later childhood: birth cohort study. BMJ 328 (2004) 925-926
14. Maher J.E., Mullooly J.P., Drew L., and DeStefano F. Infant vaccinations and childhood asthma among full-term infants. Pharmacoepidemiol Drug Saf 13 (2004) 1-9
15. Bernsen R.M., de Jongste J.C., Koes B.W., Aardoom H.A., and van der Wouden J.C. Diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic disorders in 8-12-year-old children. Vaccine 24 (2006) 2035-2042
16. Anderson H.R., Poloniecki J.D., Strachan D.P., Beasley R., Bjorksten B., and Asher M.I. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health 91 (2001) 1126-1129
17. Nilsson L., Kjellman N.I., and Bjorksten B. A randomized controlled trial of the effect of pertussis vaccines on atopic disease. Arch Pediatr Adolesc Med 152 (1998) 734-738
18. Henderson J., North K., Griffiths M., Harvey I., and Golding J. Pertussis vaccination and wheezing illnesses in young children: prospective cohort study. The Longitudinal Study of Pregnancy and Childhood Team. BMJ 318 (1999) 1173-1176
19. Mullooly J.P., Pearson J., Drew L., Schuler R., Maher J., Gargiullo P., et al. Wheezing lower respiratory disease and vaccination of full-term infants. Pharmacoepidemiol Drug Saf 11 (2002) 21-30
20. Richards A., and Sheridan J. Reasons for delayed compliance with the childhood vaccination schedule and some failings of computerised vaccination registers. Aust N Z J Public Health 23 (1999) 315-317
21. Sporton R.K., and Francis S.A. Choosing not to immunize: are parents making informed decisions?. Fam Pract 18 (2001) 181-188
22. Williams L.K., Peterson E.L., Pladevall M., Tunceli K., Ownby D.R., and Johnson C.C. Timing and intensity of early fevers and the development of allergies and asthma. J Allergy Clin Immunol 116 (2005) 102-108
23. Manitoba Health. Manitoba Immunization Monitoring System Report (1997), Manitoba Health, Winnipeg
24. Kozyrskyj A.L., and Mustard C.A. Validation of an electronic, population-based prescription database. Ann Pharmacother 32 (1998) 1152-1157
25. Robinson J.R., Young T.K., Roos L.L., and Gelskey D.E. Estimating the burden of disease: comparing administrative data and self-reports. Med Care 35 (1997) 932-947
26. Kozyrskyj A.L., and Becker A.B. Identifying childhood asthma from health care database records: is it valid?. Allergy Asthma Clin Immunol 1 (2005) 108
27. Kozyrskyj A.L., Ernst P., and Becker A.B. Increased risk of childhood asthma from antibiotic use in early life. Chest 131 (2007) 1753-1759
28. Halsey N., and Galazka A. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Org 63 (1985) 1151-1169
29. Bremner S.A., Carey I.M., DeWilde S., Richards N., Maier W.C., Hilton S.R., et al. Timing of routine immunisations and subsequent hay fever risk. Arch Dis Child 90 (2005) 567-573
30. Alm J.S., Swartz J., Lilja G., Scheynius A., and Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 353 (1999) 1485-1488
31. Bobo J.K., Gale J.L., Thapa P.B., and Wassilak S.G. Risk factors for delayed immunization in a random sample of 1163 children from Oregon and Washington. Pediatrics 91 (1993) 308-314
32. Strachan D.P. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 55 (2000) S2-S10
33. Fine P.E., and Chen R.T. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol 136 (1992) 121-135
34. Sato Y., and Sato H. Development of acellular pertussis vaccines. Biologicals 27 (1999) 61-69
35. Ball T.M., Castro-Rodriguez J.A., Griffith K.A., Holberg C.J., Martinez F.D., and Wright A.L. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 343 (2000) 538-543
36. Kozyrskyj A.L., Carrie A.G., Mazowita G.B., Lix L.M., Klassen T.P., and Law B.J. Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all children. CMAJ 171 (2004) 133-138
37. Davis R.L., Kolczak M., Lewis E., Nordin J., Goodman M., Shay D.K., et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology 16 (2005) 336-341
38. Kuno-Sakai H., and Kimura M. Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization. Pediatr Int 46 (2004) 650-655
39. Dinarello C.A. Cytokines as endogenous pyrogens. J Infect Dis 179 suppl 2 (1999) S294-S304
40. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 113 (2004) 395-400
41. Marodi L. Down-regulation of Th1 responses in human neonates. Clin Exp Immunol 128 (2002) 1-2
42. Levy O. Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J Endotoxin Res 11 (2005) 113-116
43. Nakatani H., Sano T., and Iuchi T. Development of vaccination policy in Japan: current issues and policy directions. Jpn J Infect Dis 55 (2002) 101-111
44. Laskar M.S., and Harada N. Trends and regional variations in infant mortality rates in Japan, 1973-1998. Public Health 119 (2005) 659-663
45. Ohkuni H., Kitaura T., Tamai T., Takasugi Y., Sugimoto T., and Fukai K. Efficacy of acellular pertussis vaccine in Japan: comparison of two areas, one area where immunization started at 6 months and the other area at over 2 years of age: Regional Surveillance Committee on Tuberculosis and Infectious Diseases of Osaka. Tokai J Exp Clin Med 13 suppl (1988) 51-54
46. Millar W.J., and Hill G.B. Childhood asthma. Health Rep 10 (1998) 9-21
47. Health Canada. Respiratory diseases in Canada: asthma (2001), Health Canada, Ottawa pp 33-44
48. Krahn M.D., Berka C., Langlois P., and Detsky A.S. Direct and indirect costs of asthma in Canada, 1990. CMAJ 154 (1996) 821-831
49. Boyce T.G., Weaver A.L., St Sauver J.L., Woodward-Lee A.E., Stancl J.K., Park J.Y., et al. Pertussis vaccination and the risk of respiratory syncytial virus-associated hospitalization. Pediatr Infect Dis J 23 (2004) 897-901